Ertugliflozin L-pyroglutamic acid
≥99%
blur_circular Chemical Specifications
description Product Description
Used primarily in the treatment of type 2 diabetes, it works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, promoting the excretion of glucose through urine. This helps in lowering blood sugar levels effectively. It is often prescribed as part of a comprehensive diabetes management plan, which includes diet and exercise. Additionally, it has shown benefits in reducing the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease. The compound is typically administered orally, making it convenient for long-term use. It is also being studied for potential benefits in weight management and kidney protection in diabetic patients.
shopping_cart Available Sizes & Pricing
Cart
No products